KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) FCF Margin (2016 - 2025)

Gilead Sciences (GILD) has disclosed FCF Margin for 17 consecutive years, with 39.39% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin rose 203.0% year-over-year to 39.39%, compared with a TTM value of 32.12% through Dec 2025, down 372.0%, and an annual FY2025 reading of 32.12%, down 372.0% over the prior year.
  • FCF Margin was 39.39% for Q4 2025 at Gilead Sciences, down from 50.98% in the prior quarter.
  • Across five years, FCF Margin topped out at 55.24% in Q3 2024 and bottomed at 10.17% in Q2 2025.
  • Average FCF Margin over 5 years is 32.76%, with a median of 32.81% recorded in 2023.
  • Peak annual rise in FCF Margin hit 3208bps in 2024, while the deepest fall reached -1614bps in 2024.
  • Year by year, FCF Margin stood at 42.09% in 2021, then decreased by -23bps to 32.29% in 2022, then fell by -15bps to 27.47% in 2023, then skyrocketed by 36bps to 37.36% in 2024, then grew by 5bps to 39.39% in 2025.
  • Business Quant data shows FCF Margin for GILD at 39.39% in Q4 2025, 50.98% in Q3 2025, and 10.17% in Q2 2025.